Show simple item record

dc.creatorBlanco Barrantes, Jeimy
dc.creatorQuesada Morúa, María Soledad
dc.creatorRojas Céspedes, Gustavo
dc.creatorLoría Gutiérrez, Arlene
dc.date.accessioned2022-07-28T21:00:58Z
dc.date.available2022-07-28T21:00:58Z
dc.date.issued2021
dc.identifier.citationhttp://www.ijdra.com/index.php/journal/article/view/454es_ES
dc.identifier.issn2321-6794
dc.identifier.urihttps://hdl.handle.net/10669/87077
dc.description.abstractThis review describes the evolution and development of drug quality control throughout different times in history. A bibliographic research was conducted from the database JSTOR from the University of Costa Rica. This database contains information from academic journals and books from XIX to date. It covers different fields, such as anthropology, arts, biology, botany, health sciences, politics, pharmacy, history. Information was retrieved when the following words were present: pharmacy, quality, quality control, drugs, medicines, pharmacopoeia. In ancient history India, China, Greece, Egypt, Africa and America used different medicinal plants to cure or alleviate disease. In some of these regions, methods were developed to make medicinal preparations as safe and effective as possible. In ancient Greece, the need to have a complete knowledge of drugs to carry out their proper preparation and detect adulterations was emerging. In Europe there was a constant development in the field, from books containing simple lists of preparations and medicines to more complex pharmacopoeias that included quality of the medicines. In America, the United States Pharmacopoeia (USP) first appeared in 1820. In Costa Rica, the Specialized Laboratory for Drug Analysis, actually the Laboratory for Analysis and Pharmaceutical Consulting (LAYAFA), was created in 1965, to ensure the quality and safety of medicines registered and marketed in Costa Rica. Differences between regulations and quality standards across centuries and countries, and their impact on the commercialization of medicines, have promoted regulations to harmonize the requirements related to different activities of the processes of manufacture, registration and quality control of medicines.es_ES
dc.language.isoenges_ES
dc.sourceInternational Journal of Drug Regulatory Affairs, 9(1), 33-47es_ES
dc.subjectQuality Control of Medicineses_ES
dc.subjectLAYAFAes_ES
dc.subjectCOSTA RICAes_ES
dc.subjectFARMACOLOGÍAes_ES
dc.subjectPHARMACOLOGYes_ES
dc.subjectMEDICINA CLÍNICAes_ES
dc.subjectDRUGSes_ES
dc.titleA Journey through the History of Drug Quality Control, from Greece to Costa Ricaes_ES
dc.typeartículo científicoes_ES
dc.identifier.doihttps://doi.org/10.22270/ijdra.v9i1.454
dc.description.procedenceUCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias de la Salud::Instituto de Investigaciones Farmacéuticas (INIFAR)es_ES
dc.description.procedenceUCR::Vicerrectoría de Docencia::Salud::Facultad de Farmaciaes_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record